Persistent parasites and immunologic memory in cutaneous leishmaniasis: Implications for vaccine designs and vaccination strategies

Immunologic Research

Volumn 41, Issue 2, 2008, Pages 123-136

  Okwor, Ifeoma ^a   Uzonna, Jude ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Infection induced immunity; Leishmania; Memory T cells; Parasite persistence; Vaccination

Indexed keywords

CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; L SELECTIN; LEISHMANIA VACCINE;

CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNOLOGICAL MEMORY; LEISHMANIA MAJOR; MEMORY T LYMPHOCYTE; NONHUMAN; PARASITE CONTROL; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SKIN LEISHMANIASIS; VACCINATION; ANIMAL; IMMUNOLOGY; METABOLISM; MOUSE; PARASITOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; LEISHMANIA MAJOR; LEISHMANIASIS VACCINES; LEISHMANIASIS, CUTANEOUS; MICE; T-LYMPHOCYTES, REGULATORY; VACCINATION;

EID: 53749088914     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-008-8016-2     Document Type: Review

References (103)

1. SL Swain JN Agrewala DM Brown E Roman 2002 Regulation of memory CD4 T cells: generation, localization and persistence Adv Exp Med Biol. 512 113 20
2. J Sprent CD Surh 2002 T cell memory Annu Rev Immunol. 20 551 79
3. TS Gourley EJ Wherry D Masopust R Ahmed 2004 Generation and maintenance of immunological memory Semin Immunol. 16 323 33
4. JK Whitmire K Murali-Krishna J Altman R Ahmed 2000 Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements Philos Trans R Soc Lond B Biol Sci. 355 373 9
5. MK Slifka 2004 Immunological memory to viral infection Curr Opin Immunol. 16 443 50
6. RM Zinkernagel H Hengartner 2004 On immunity against infections and vaccines: credo 2004 Scand J Immunol. 60 9 13
7. SP Brown BT Grenfell 2001 An unlikely partnership: parasites, concomitant immunity and host defence Proc Biol Sci. 268 2543 9
8. BJ Manfras S Reuter T Wendland BO Boehm P Kern 2004 Impeded Th1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis Int Immunol. 16 43 50
9. DA Brake 2003 Parasites and immune responses: memory illusion? DNA Cell Biol. 22 405 19
10. MC Albareda SA Laucella MG Alvarez AH Armenti G Bertochi RL Tarleton M Postan 2006 Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients Int Immunol. 18 465 71
11. P Desjeux 2004 Leishmaniasis Nat Rev Microbiol. 2 692
12. P Desjeux 1992 Human leishmaniases: epidemiology and public health aspects World Health Stat Q. 45 267 75
13. P Desjeux 2004 Leishmaniasis: current situation and new perspectives Comp Immunol Microbiol Infect Dis. 27 305 18
14. J Berman 2003 Current treatment approaches to leishmaniasis Curr Opin Infect Dis. 16 397 401
15. Y. Vanloubbeeck DE Jones 2004 The immunology of Leishmania infection and the implications for vaccine development Ann N Y Acad Sci. 1026 267 72
16. SL Reiner RM Locksley 1995 The regulation of immunity to Leishmania major Annu Rev Immunol. 13 151 77
17. P Scott 1996 Th cell development and regulation in experimental cutaneous leishmaniasis Chem Immunol. 63 98 114
18. RM Locksley FP Heinzel BJ Holaday SS Mutha SL Reiner MD Sadick 1991 Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection Res Immunol. 142 28 32
19. T Scharton-Kersten LC Afonso M Wysocka G Trinchieri P Scott 1995 IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis J Immunol. 154 5320 30
20. P Scott E Pearce AW Cheever RL Coffman A Sher 1989 Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease Immunol Rev. 112 161 82
21. P Scott 1989 The role of Th1 and Th2 cells in experimental cutaneous leishmaniasis Exp Parasitol. 68 369 72
22. LC Afonso TM Scharton LQ Vieira M Wysocka G Trinchieri P Scott 1994 The adjuvant effect of interleukin-12 in a vaccine against Leishmania major Science. 263 235 7
23. AY Park P Scott 2001 Il-12: keeping cell-mediated immunity alive Scand J Immunol. 53 529 32
24. D Jones MM Elloso L Showe D Williams G Trinchieri P Scott 1998 Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major Infect Immun. 66 3818 24
25. H Himmelrich C Parra-Lopez F Tacchini-Cottier JA Louis P Launois 1998 The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12 J Immunol. 161 6156 63
26. J Louis H Himmelrich C Parra-Lopez F Tacchini-Cottier P Launois 1998 Regulation of protective immunity against Leishmania major in mice Curr Opin Immunol. 10 459 64
27. MM Kane DM Mosser 2001 The role of IL-10 in promoting disease progression in leishmaniasis J Immunol. 166 1141 7
28. H Groux F Cottrez M Rouleau S Mauze S Antonenko S Hurst T McNeil M Bigler MG Roncarolo RL Coffman 1999 A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells J Immunol. 162 1723 9
29. TR Mosmann KW Moore 1991 The role of IL-10 in cross-regulation of Th1 and Th2 responses Immunol Today. 12 A49 53
30. R Chatelain S Mauze RL Coffman 1999 Experimental Leishmania major infection in mice: role of IL-10 Parasite Immunol. 21 211 8
31. Y Belkaid 2003 The role of CD4+CD25+ regulatory T cells in Leishmania infection Expert Opin Biol Ther. 3 875 85
32. Y Belkaid CA Piccirillo S Mendez EM Shevach DL Sacks 2002 CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity Nature. 420 502 7
33. B Hondowicz P Scott 1999 Influence of host and parasite factors on the innate immune response and Th2 stability following infection with Leishmania major Microbes Infect. 1 65 71
34. A Gumy JA Louis P Launois 2004 The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds Int J Parasitol. 34 433 44
35. E von Stebut MC Udey 2004 Requirements for Th1-dependent immunity against infection with Leishmania major Microbes Infect. 6 1102 9
36. D Sacks N Noben-Trauth 2002 The immunology of susceptibility and resistance to Leishmania major in mice Nat Rev Immunol. 2 845 58
37. A Nadim E Javadian G Tahvildar-Bidruni M Ghorbani 1983 Effectiveness of leishmanization in the control of cutaneous leishmaniasis Bull Soc Pathol Exot Filiales. 76 377 83
38. F Modabber 1989 Experiences with vaccines against cutaneous leishmaniasis: of men and mice Parasitology. 98 Suppl S49 60
39. EE Shuikina VP Sergiev II Triers VA Shcherbakov S Diveev 1968 [Experience of antileishmaniasis vaccinations with cultures of Leishmania tropica major grown in various types of media] Med Parazitol (Mosk). 37 648 51
40. PG Sergiev RI Beislekhem ShD Moshkovskii NA Demina OI Kellina 1970 Results of massive vaccination against zoonotic cutaneous leishmaniasis Med Parazitol (Mosk). 39 541 51
41. A Khamesipour Y Dowlati A Asilian R Hashemi-Fesharki A Javadi S Noazin F Modabber 2005 Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis Vaccine. 23 3642 8
42. I Muller 1992 Role of T cell subsets during the recall of immunologic memory to Leishmania major Eur J Immunol. 22 3063 9
43. I Muller P Kropf RJ Etges JA Louis 1993 Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells Infect Immun. 61 3730 8
44. AY Park BD Hondowicz P Scott 2000 IL-12 is required to maintain a Th1 response during Leishmania major infection J Immunol. 165 896 902
45. L Stobie S Gurunathan C Prussin DL Sacks N Glaichenhaus CY Wu RA Seder 2000 The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge Proc Natl Acad Sci USA. 97 8427 32
46. AY Park B Hondowicz M Kopf P Scott 2002 The role of IL-12 in maintaining resistance to Leishmania major J Immunol. 168 5771 7
47. C Zaph J Uzonna SM Beverley P Scott 2004 Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites Nat Med. 10 1104 10
48. P Scott 2005 Immunologic memory in cutaneous leishmaniasis Cell Microbiol. 7 1707 13
49. P Scott D Artis J Uzonna C Zaph 2004 The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development Immunol Rev. 201 318 38
50. JE Uzonna G Wei D Yurkowski P Bretscher 2001 Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease J Immunol. 167 6967 74
51. IJ Suffia SK Reckling CA Piccirillo RS Goldszmid Y Belkaid 2006 Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens J Exp Med. 203 777 88
52. RW Dutton LM Bradley SL Swain 1998 T cell memory Annu Rev Immunol. 16 201 23
53. D Gray P Matzinger 1991 T cell memory is short-lived in the absence of antigen J Exp Med. 174 969 74
54. F Sallusto J Geginat A Lanzavecchia 2004 Central memory and effector memory T cell subsets: function, generation, and maintenance Annu Rev Immunol. 22 745 63
55. DF Tough 2003 Deciphering the relationship between central and effector memory CD8+ T cells Trends Immunol. 24 404 7
56. F Sallusto D Lenig R Forster M Lipp A Lanzavecchia 1999 Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature. 401 708 12
57. F Sallusto A Lanzavecchia 2001 Exploring pathways for memory T cell generation J Clin Invest. 108 805 6
58. EJ Wherry V Teichgraber TC Becker D Masopust SM Kaech R Antia UH von Andrian R Ahmed 2003 Lineage relationship and protective immunity of memory CD8 T cell subsets Nat Immunol. 4 225 34
59. SM Kaech R Ahmed 2001 Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells Nat Immunol. 2 415 22
60. RL Reinhardt A Khoruts R Merica T Zell MK Jenkins 2001 Visualizing the generation of memory CD4 T cells in the whole body Nature. 410 101 5
61. T Aebischer SF Moody E Handman 1993 Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host Infect Immun. 61 220 6
62. T Aebischer 1994 Recurrent cutaneous leishmaniasis: a role for persistent parasites? Parasitol Today. 10 25 8
63. N Berhe A Hailu D Wolday Y Negesse P Cenini D Frommel 1995 Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus Trans R Soc Trop Med Hyg. 89 205 7
64. D. Wolday N Berhe H Akuffo S Britton 1999 Leishmania-HIV interaction: immunopathogenic mechanisms Parasitol Today. 15 182 7
65. D Wolday N Berhe H Akuffo P Desjeux S Britton 2001 Emerging Leishmania/HIV co-infection in Africa Med Microbiol Immunol (Berl). 190 65 7
66. NG Saravia K Weigle I Segura SH Giannini R Pacheco LA Labrada A Goncalves 1990 Recurrent lesions in human Leishmania braziliensis infection-reactivation or reinfection? Lancet. 336 398 402
67. S Stenger N Donhauser H Thuring M Rollinghoff C Bodgan 1996 Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase J Exp Med. 183 1501 14
68. S Mendez SK Reckling CA Piccirillo D Sacks Y Belkaid 2004 Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity J Exp Med. 200 201 10
69. JE Uzonna PA Bretscher 2001 Anti-IL-4 antibody therapy causes regression of chronic lesions caused by medium-dose Leishmania major infection in BALB/c mice Eur J Immunol. 31 3175 84
70. AP Campanelli AM Roselino KA Cavassani MS Pereira RA Mortara CI Brodskyn HS Goncalves Y Belkaid M Barral-Netto A Barral JS Silva 2006 CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells J Infect Dis. 193 1313 22
71. E Bourreau G Prevot J Gardon R Pradinaud P Launois 2001 High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment J Infect Dis. 184 1628 30
72. GR Habibi A Khamesipour WR McMaster F Mahboudi 2001 Cytokine gene expression in healing and non-healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi-quantitative RT-PCR Scand J Immunol. 54 414 20
73. GF Spath LF Lye H Segawa DL Sacks SJ Turco SM Beverley 2003 Persistence Without Pathology in Phosphoglycan-Deficient Leishmania major Science. 301 1241 3
74. LL Lau BD Jamieson T Somasundaram R Ahmed 1994 Cytotoxic T-cell memory without antigen Nature. 369 648 52
75. SL Swain 2000 CD4 T-cell memory can persist in the absence of class II Philos Trans R Soc Lond B Biol Sci. 355 407 11
76. D Gray 2002 A role for antigen in the maintenance of immunological memory Nat Rev Immunol. 2 60 5
77. RM Zinkernagel 2002 On differences between immunity and immunological memory Curr Opin Immunol. 14 523 36
78. EJ Wherry MJ McElhaugh LC Eisenlohr 2002 Generation of CD8(+) T cell memory in response to low, high, and excessive levels of epitope J Immunol. 168 4455 61
79. GV Brown 1999 Progress in the development of malaria vaccines: context and constraints Parassitologia. 41 429 32
80. J Andreassen 1991 Immunity to adult cestodes: basic knowledge and vaccination problems. A review Parassitologia. 33 45 53
81. S Rajakumar W Bleiss S Hartmann P Schierack A Marko R Lucius 2006 Concomitant immunity in a rodent model of filariasis: the infection of Meriones unguiculatus with Acanthocheilonema viteae J Parasitol. 92 41 5
82. SS Struik EM Riley 2004 Does malaria suffer from lack of memory? Immunol Rev. 201 268 90
83. CF Anderson S Mendez DL Sacks 2005 Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice J Immunol. 174 2934 41
84. RG Titus FJ Gueiros-Filho LA de Freitas SM Beverley 1995 Development of a safe live Leishmania vaccine line by gene replacement Proc Natl Acad Sci USA. 92 10267 71
85. JE Uzonna GF Spath SM Beverley P Scott 2004 Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response J Immunol. 172 3793 7
86. F Modabber 1995 Vaccines against leishmaniasis Ann Trop Med Parasitol. 89 Suppl 1 83 8
87. KB Marzochi MA Marzochi AF Silva N Grativol R Duarte EM Confort F Modabber 1998 Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil Mem Inst Oswaldo Cruz. 93 205 12
88. I Sharifi AR FeKri MR Aflatonian A Khamesipour A Nadim MR Mousavi AZ Momeni Y Dowlati T Godal F Zicker PG Smith F Modabber 1998 Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran Lancet. 351 1540 3
89. AZ Momeni T Jalayer M Emamjomeh A Khamesipour F Zicker RL Ghassemi Y Dowlati I Sharifi M Aminjavaheri A Shafiei MH Alimohammadian R Hashemi-Fesharki K Nasseri T Godal PG Smith F Modabber 1999 A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran Vaccine. 17 466 72
90. ID Velez S del Pilar Agudelo MP Arbelaez K Gilchrist SM Robledo JA Puerta F Zicker J Berman F Modabber 2000 Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial Trans R Soc Trop Med Hyg. 94 698 703
91. EA Khalil AM El Hassan EE Zijlstra MM Mukhtar HW Ghalib B Musa ME Ibrahim AA Kamil M Elsheikh A Babiker F Modabber 2000 Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan Lancet. 356 1565 9
92. M Mahmoodi A Khamesipour Y Dowlati S Rafati AZ Momeni M Emamjomeh H Hejazi F Modabber 2003 Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG Clin Exp Immunol. 134 303 8
93. RX Armijos MM Weigel M Calvopina A Hidalgo W Cevallos J Correa 2004 Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis Vaccine. 22 1320 6
94. S Gurunathan DL Sacks DR Brown SL Reiner H Charest N Glaichenhaus RA Seder 1997 Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major J Exp Med. 186 1137 47
95. GF Mitchell E Handman 1983 Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility Aust J Exp Biol Med Sci. 61 11 25
96. E Handman AH Noormohammadi JM Curtis T Baldwin A Sjolander 2000 Therapy of murine cutaneous leishmaniasis by DNA vaccination Vaccine. 18 3011 7
97. VO da Silva GP Borja-Cabrera NN Correia Pontes EP de Souza KG Luz M Palatnik CB de Palatnik Sousa 2000 A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN) Vaccine. 19 1082 92
98. T Aebischer M Wolfram SI Patzer T Ilg M Wiese P Overath 2000 Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants Infect Immun. 68 1328 36
99. S Stager DF Smith PM Kaye 2000 Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis J Immunol. 165 7064 71
100. SB Ahmed C Bahloul C Robbana S Askri K Dellagi 2004 A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major Vaccine. 22 1631 9
101. DA Vardy A Cohen L Kachko A Zvulunov S Frankenburg 1999 Relapse of cutaneous leishmaniasis in a patient with an infected subcutaneous rheumatoid nodule Br J Dermatol. 141 914 7
102. C Kebaier JE Uzonna SM Beverley P Scott 2006 Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice Infect Immun. 74 777 80
103. P Veras C Brodskyn F Balestieri F Ld A Ramos A Queiroz A Barral S Beverley M Barral-Netto 1999 A dhfr-ts- leishmania major knockout mutant cross-protects against leishmania amazonensis [In Process Citation] Mem Inst Oswaldo Cruz. 94 491 6